EASL clinical practice guidelines: management of hepatocellular carcinoma
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies,
are at a high risk of developing hepatocellular carcinoma (HCC). Even after complete HCC …
are at a high risk of developing hepatocellular carcinoma (HCC). Even after complete HCC …
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
P Lampertico, K Agarwal, T Berg, M Buti… - Journal of …, 2017 - Elsevier
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …
epidemiology due to several factors including vaccination policies and migration. This …
Current trend in antiviral therapy for chronic hepatitis B
RN Chien, YF Liaw - Viruses, 2022 - mdpi.com
Since active hepatitis B virus (HBV) replication is the key driver of hepatic necroinflammation
and disease progression, the treatment aim of chronic hepatitis B (CHB) is to suppress HBV …
and disease progression, the treatment aim of chronic hepatitis B (CHB) is to suppress HBV …
[PDF][PDF] The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
Whether there is a change of hepatocellular carcinoma (HCC) incidence in chronic hepatitis
B patients under long‐term therapy with potent nucleos (t) ide analogues is currently …
B patients under long‐term therapy with potent nucleos (t) ide analogues is currently …
[HTML][HTML] Guidelines for prevention and treatment of chronic hepatitis B
G Wang, Z Duan - Journal of clinical and translational hepatology, 2021 - ncbi.nlm.nih.gov
To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major
public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese …
public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese …
Hepatitis B virus infection
MF Yuen, DS Chen, GM Dusheiko… - Nature reviews Disease …, 2018 - nature.com
Hepatitis B virus (HBV) is a hepatotropic virus that can establish a persistent and chronic
infection in humans through immune anergy. Currently, 3.5% of the global population is …
infection in humans through immune anergy. Currently, 3.5% of the global population is …
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
K Tarao, A Nozaki, T Ikeda, A Sato, H Komatsu… - Cancer …, 2019 - Wiley Online Library
Background It is well known that the incidence of developing hepatocelluler carcinoma
(HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC …
(HCC) is increased in liver cirrhosis of different etiologies. However, comparison of HCC …
慢性乙型肝炎防治指南(2019 年版).
王贵强， 段钟平 - Journal of Clinical Hepatology/Linchuang …, 2019 - search.ebscohost.com
中华医学会感染病学分会,中华医学会肝病学分会 Page 1 +,-. 慢性乙型肝炎防治指南(2019 年版
) 中华医学会感染病学分会,中华医学会肝病学分会 摘要:为了实现世界卫生组织提出的“2030 年 …
) 中华医学会感染病学分会,中华医学会肝病学分会 摘要:为了实现世界卫生组织提出的“2030 年 …
Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol‐inducible cytochrome P450‐2E1–mediated oxidative and nitrative stress
Fructose intake is known to induce obesity, insulin resistance, metabolic syndrome, and
nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the effects of fructose …
nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the effects of fructose …